Researchers at the University of Cologne and University Hospital Cologne have determined that the novel mRNA-based COVID-19 ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

A handful of states are targeting the technology at the same time the Trump administration is cutting research funding and ...

The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.

Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

Rep. Marjorie Taylor Greene calls for yanking FDA approval of COVID-19 vaccines, says that "COVID-19 vaccines are causing ...

Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against potential ...

In a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac ...